6.69 USD
+0.06 (+0.9%)
6.71 USD
+0.02 (+0.3%)
ChartMill assigns a Buy % Consensus number of 83% to VIR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 17.57. This target is 162.58% above the current price.
VIR was analyzed by 14 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about VIR.
In the previous month the buy percentage consensus was at a similar level.
VIR was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-09-03 | Evercore ISI Group | Initiate | Outperform |
| 2025-08-27 | B of A Securities | Upgrade | Neutral -> Buy |
| 2025-07-11 | Raymond James | Initiate | Outperform |
| 2025-05-22 | Needham | Reiterate | Buy -> Buy |
| 2025-05-12 | Needham | Maintains | Buy -> Buy |
| 2025-04-17 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-02-28 | Barclays | Maintains | Overweight -> Overweight |
| 2025-02-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-27 | Needham | Reiterate | Buy -> Buy |
| 2025-01-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-13 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2025-01-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-09 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-01-09 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |
| 2024-11-20 | Needham | Reiterate | Buy -> Buy |
| 2024-11-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-04 | Barclays | Maintains | Overweight -> Overweight |
| 2024-11-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-01 | Needham | Reiterate | Buy -> Buy |
| 2024-08-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-02 | Barclays | Maintains | Overweight -> Overweight |
| 2024-06-06 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-06-05 | Needham | Maintains | Buy -> Buy |
| 2024-06-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-03 | Needham | Reiterate | Buy -> Buy |
| 2024-05-03 | JP Morgan | Maintains | Neutral -> Neutral |
| 2024-03-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
VIR BIOTECHNOLOGY INC / VIR FAQ
Can you provide the average price target for VIR BIOTECHNOLOGY INC stock?
14 analysts have analysed VIR and the average price target is 17.57 USD. This implies a price increase of 162.58% is expected in the next year compared to the current price of 6.69.
Can you provide the consensus rating for VIR BIOTECHNOLOGY INC stock?
The consensus rating for VIR BIOTECHNOLOGY INC (VIR) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover VIR BIOTECHNOLOGY INC (VIR) stock?
The number of analysts covering VIR BIOTECHNOLOGY INC (VIR) is 14.